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Background: Among patients with substance use disorder (SUD), major depressive
disorder (MDD) is highly prevalent. Even though, personality plays an important role in
treatment outcomes for individuals with SUD and SUD+MDD, few studies have explored
personality characteristics in these samples. This study aims to describe personality for
patients with SUD taking into account the comorbid MDD, using the Alternative Five
Factor Model (AFFM). We also aim to compare SUD + MDD patients with population
norms and to elucidate possible personality clinical correlates.
Methods: For our study, 116 male patients undergoing for SUD treatment were divided
in two groups: SUD only (N = 58) and SUD + MDD (N = 58). To examine personality,
we used the Zuckerman-Kuhlman Personality Questionnaire and multiple analyses of
covariance were performed to identify differences. In a first analysis, age was introduced
as a covariate whereas in a second analysis the continuous variables that showed to have
a discriminant value for the groups were added as covariates. Variables predicting the
presence of dual diagnosis and personality clinical correlates were analyzed by logistic
and linear regression models, respectively. We observed that patients with SUD + MDD
show distinctive personality characteristics compared with patients with SUD only and
population norms.
Results: According to the AFFM, SUD + MDD patients are characterized by higher
Neuroticism-Anxiety (positively associated to depressive symptoms) and Impulsivity; and
by lower Parties and Friends. Moreover, the probability of having a dual depressive
disorder was represented by the amount of medications and substances used. The
preference for hard work and the energy self-reported levels (Work Activity trait) are
linked to these clinical variables rather than to the presence/absence of a dual depressive
disorder.
Marquez-Arrico et al. Addiction, Comorbid Depression and Personality
Conclusions: Even when controlling clinical variables related to a higher probability
of having a dual depressive disorder, the Neuroticism-Anxiety is a personality trait that
strongly differentiates between SUD only and SUD+MDD patients. Further investigation
is needed to explore the role of this personality trait as endophenotype in dual depressive
men. Our results underline the importance of a dimensional understanding of personality
and its clinical correlates among patients with SUD +MDD; this approach could provide
us information on specific treatment strategies to improve the prognosis of patients.
Keywords: comorbid depression, substance use disorder, personality profile, dual disorders, alternative five factor
model
INTRODUCTION
Research has shown than personality characteristics need to be
considered in order to accomplish a deeper knowledge which
allows to improve both theoretical and practical comprehension
of substance use disorders (SUD) (1–3). Moreover, SUD and
comorbid major depression disorder (MDD) is highly prevalent
(4, 5) and personality characteristics also influence on clinical
features and treatment response among patients with both
disorders (6, 7). Having a SUD and a comorbid MDD (SUD
+ MDD) is strongly associated to alcohol/cocaine dependence
(8, 9), more severe depressive episodes (10) and major clinical
complications during treatment (11, 12) compared with having
SUD only. Therefore, the study of clinical features of patients
with SUD + MDD is an interesting topic for both researchers
and clinical practitioners.
In this sense, as a result of such complications associated to
comorbidity of both disorders, recent research has attempted
to identify personality variables related to SUD with psychiatric
comorbidity and tried to elucidate clinical correlates (13–16).
The majority of the research about personality in patients with
SUD has been conducted from a psychobiological perspective
which has shown to be more sensitive to these patients’ specific
personality characteristics. Accordingly, studies have found that
elevated scores in Impulsivity and Sensation Seeking personality
traits are associated to developing a SUD (17), to a stronger
craving for patients with SUD, higher severity of addiction (18,
19) and more relapses (17, 20). Moreover, low scores in traits
like Reward Dependence, Persistence, Cooperation, and Self-
Transcendence (from Cloninger’s Temperament and Character
Inventory) are strongly related to dropping-out SUD treatment
(21).
On the other hand, research about personality in patients
with MDD indicated that high Extraversion, Agreeableness,
and Conscientiousness (from NEO’s Five Factor Inventory)
significantly reduced the risk of a new depressive episode, while
only Neuroticism predicted a new episode (7).
Regarding personality in patients with SUD + MDD,
data up to now have shown that, compared with SUD or
MDD only patients, they have higher Neuroticism (from NEO
Five Factor Inventory) (22), Novelty Seeking (23, 24), Harm
Avoidance (25), and lower Persistence, Self-Directedness, and
Cooperativeness (23, 24) (from Cloninger’s Temperament and
Character Inventory). These findings are relevant as personality
is related to the clinical course of patients with and SUD +
MDD, with high scores in Harm Avoidance being associated to
dysphoric episodes (26), severe depressive symptomatology (27),
and poorer response to antidepressant treatment (28).
In sum, the influence of specific personality dimensions
on addictive disorders and psychopathology conditions like
MDD has accumulated sufficient scientific background to be
worth considering (29). However, to our knowledge the possible
differences between patients with SUD only and with SUD +
MDD have not been studied to analyze the role of depression
in personality traits of patients with drug dependence. For all
these reasons, we have chosen to explore such issue using the
Alternative Five Factor Model of personality due to its theoretical
background, psychobiological perspective, cross-cultural validity
(30), and good psychometric properties in psychiatric samples
(31).
As far as we know, this is the first study that uses the
Alternative Five Factor Model to examine personality differences
between patients with SUD and SUD+MDD, which also aims to
compared them with population norms. Additionally, we seek to
identify whether personality characteristics could be associated to
clinical features related to both SUD and MDD diagnoses.
MATERIALS AND METHODS
Participants
Our total sample was comprised by 116 male patients (mean
= 40.58 years; SD = 8.03) undergoing treatment for their SUD
in public and private centers, who were divided in two groups
regarding their diagnosis: SUD only (N = 58) and comorbid SUD
+ MDD (N = 58). All participants were referred to the study
by their psychologist and psychiatrist; those providing written
informed consent were included in the study and assessed by
an experienced postgraduate psychologist. The majority of the
measures were collected during the morning because patients
from our treatment centers are under therapeutic interventions
that are highly structured following the light-dark rhythm.
The inclusion criteria were as follows: (1) current diagnosis of
SUD, according to DSM-5 (with no depressive symptoms to be
included in the SUD only group) (32), in remission for at least
3 months and with no relapses, confirmed by urinalysis in each
treatment center; (2) male gender (as this is the most prevalent
gender among people with a SUD diagnosis and in patients from
our treatment centers); (3) aged 22–55 years; (4) those patients
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having a co-occurring diagnosis were only included if they met
criteria for MDD. The exclusion criteria were: (1) meeting DSM-
5 criteria for a current substance-induced psychiatric disorder
or a psychiatric disorder due to medical condition; (2) unstable
or uncontrolled psychiatric symptomatology; (3) inability to
complete study instruments.
The University of Barcelona ethics committee’s approved this
study in accordance with the ethical standards of the Helsinki
declaration. Participants were not economically compensated
for their participation but they received a report with their
personality profile through the professionals of their respective
treatment centers.
Measures
Sociodemographic and Clinical Measures
Current diagnosis of SUD and MDD was referred by treatment
providers of each respective patient and confirmed using DSM-
5 criteria. For collecting demographic and clinical variables we
used the Structural Clinical Interview for DMS-IV-TR Axis I
Disorders (SCID-I) (33), as the Spanish version of the SCID from
DSM-5 was not available during the developing of our study,
along with a clinical interview designed for our study.
The Spanish version (34) of the Drug Abuse Screening Test
(DAST-20) (35) was used to measure severity of the SUD in
both groups; this instruments provides a total score which ranges
from 0 to 20 and reveals the severity of addiction. The total
score is understood by the following cutoff points: 1–5 low, 6–10
intermediate, 11–15 substantial, and 16–20 severe (a higher score
means a higher severity of addiction).
For measuring depressive symptoms in the SUD+MDD
groupwe used theHamiltonDepression Rating Scale (HDRS) 17-
item (36); in this case the cutoff points were: 0–7 no depression,
8–13 mild, 14–18 moderate, 19–22 severe, and ≥23 very severe
depression.
Personality Assessment
Personality through the Alternative Five Factor Model was
assessed using the Spanish version of the Zuckerman-Kuhlman
Personality Questionnaire (ZKPQ) (37). This questionnaire is
composed by five scales or personality factors. The first scale
is Neuroticism-Anxiety (N-Anx); it is formed by 19 items and
describes a tendency to negative emotions and sensitivity to
criticism. The second scale is Activity (Act), formed by 17 items,
which describes the need for general activity and the preference
for hard and challenging work. The Act scale has two different
subscales: General Activity (GenAct; 9 items) and Work Activity
(WorkAct; 8 items). The third scale is Sociability (Sy), composed
by 17 items, that explains the preference for having friends and
spending time with them. Two subscales can also be obtained
from Sy, these are Parties and Friends (Part; 9 items) and
Isolation Intolerance (Isol; 8 items). The fourth scale is Impulsive
Sensation-Seeking (ImpSS), formed by 19 items, that involves a
lack of planning and the tendency to act without thinking and
looking for excitement. The ImpSS scale gives two subscales:
Impulsivity (Imp; 8 items) and Sensation Seeking (SS; 11 items).
The fifth and last personality scale is Aggression-Hostility (Agg-
Hos), composed by 17 items, which explain the tendency to
express verbal aggression as well as being rude to others. Finally,
the ZKPQ includes also an Infrequency scale (Infreq) formed
by 10 items that is used to detect inattention to the task or
understood as a validity measure rather than a normative scale.
Statistical Analyses
The main descriptive data (means, SD, frequencies) were
calculated for all variables measured for both SUD and
SUD+MDD groups. Differences in sociodemographic and
clinical variables were explored with ANOVA or Chi-square (χ ²)
test for continuous and categorical variables, respectively. To
explore which sociodemographic and clinical variables could be
related to a greater probability of being in the dual disorder group
(SUD+MDD) we carried out logistic regression analyses through
stepwise regression method. Logistic regression coefficients and
their standard errors were exponentiated to create odds-ratios
(ORs) and their 95% confidence intervals. Continuous predictors
were divided into categories to minimize the effects of extreme
values to stabilize associations.
Intergroup differences for the ZKPQ scales, considering the
SUD and SUD+MDD diagnoses, were examined by multivariate
analyses of covariance (MANCOVA) introducing group as an
independent variable and age as a covariate since it could be
a confounding factor (38). In addition, a second MANCOVA
analysis was performed adding as covariates the continuous
variables pointed out in the logistic regression analysis as
discriminating factors between the groups. In both cases we
performed one MANCOVA for the scales and another one
for the subscales. Post-hoc analyses were Bonferroni corrected
and we estimated partial Eta-square (ηp2) to measure the effect
size. Cronbach’s alpha coefficient of internal consistency was
calculated for the ZKPQ scales; as well as T scores, according
to the Spanish population norms (37), for the scales and
subscales.
Finally, to identify the possible relationships among the ZKPQ
personality scales and clinical variables (SUD and MDD related)
bivariate correlation analyses were performed. Only the scales
showing significant associations with clinical variables were
entered in the subsequent multiple linear stepwise regression
analysis. All data were analyzed using the SPSS/PC software,
version 24.0, and all statistic tests were bilateral with a p ≤ 0.05.
RESULTS
Participant’s Characteristics
The main sociodemographic and clinical features of the
sample are described in Table 1. Concerning sociodemographic
variables, groups were different in marital status (p = 0.036)
and economic situation (p = 0.008). Patients with SUD +MDD
were more likely to be single or separated/divorced than patients
with SUD only, who were more likely to be married or with a
stable partner. In addition, while patients with SUD + MDD
were characterized by being unemployed or having a disability
pension, patients with SUD only were working or having a sick
leave due to SUD treatment.
On the other hand, analyses for clinical variables revealed that
groups differed in the presence of medical disease comorbidity
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TABLE 1 | Sociodemographic and clinical data.
SUD + MDD SUD only Statistical
contrast
SOCIODEMOGRAPHIC DATA
Age (years) 42.05 ± 6.85 39.10 ± 9.36 t(98) = 1.94
Marital status χ2(4) = 10.28*
Single 44.8% 37.9%
Stable partner 3.4% 17.2%
Married 10.3% 19%
Separated/divorced 37.9% 20.7%
Widower 3.4% 5.2%
Years of schooling 10.29 ± 2.68 10.84 ± 2.74 t(98) = 1.10
Economic situation χ2(4) = 13.74**
Active 8.6% 22.4%
Unemployed 39.7% 32.8%
Disability pension 31% 8.6%
Sick leave (due SUD
treatment)
12.1% 20.5%
No income 8.6% 15.7%
CLINICAL DATA
Medical disease comorbidity 50% 31% χ2(5) = 4.32*
Hypercholesterolemia 12.1% 0%
Respiratory system
disease
12.1% 8.6%
Hepatitis 12.1% 6.9%
Diabetes 6.9% 3.4%
HIV 3.4% 1.7%
Other 3.4% 10.3%
Daily number of medications 2.05 ± 1.41 0.55 ± 1.05 t(114) = 6.48***
Type of medication prescribed
Antidepressants 74.1% 20.7% χ2(1) = 33.23***
Anxiolytics 53.4% 6.9% χ2(1) = 28.83***
Mood stabilizers 21.1% 8.6% χ2(1) = 5.10*
Interdictor 10.3% 10.3% χ2(1) = 0.01
Other 11.9% 20.7% χ2(1) = 25.14*
Quantity of substance
useda
2.83 ± 1.46 1.97 ± 0.86 t(114) = 3.87***
Alcohol 84.5% 75.9% χ2(1) = 1.36
Cocaine 79.3% 74.1% χ2(1) = 0.24
Cannabis 44.8% 32.8% χ2(1) = 2.60
Hallucinogens 20.7% 6.9% χ2(1) = 4.64*
Opioids 27.6% 5.2% χ2(1) = 10.63***
Sedatives 15.5% 1.7% χ2(1) = 7.04**
DAST-20 14.29 ± 3.14 13.64 ± 3.76 t(114) = 0.10
History of suicide attempts 41.4% 17.2% χ2(1) 8.16**
Number of lifetime suicidal
attempts
0.76 ± 1.15 0.22 ± 0.56 t(114) = 3.19**
Mean abstinence period
(months)
6.97 ± 4.50 8.84 ± 6.16 t(114) = 1.88
Substance use disorder age
onset (years)
18.88 ± 7.11 19.53 ± 5.90 t(114) = 0.54
(Continued)
TABLE 1 | Continued
SUD + MDD SUD only Statistical
contrast
History of substance use
(years)
23.17 ± 9.91 19.57 ±10.31 t(114) = 1.91
Major depressive disorder
age onset (years)
30.81 ± 8.72
HDRS 11.26 ± 4.81
Means and standard deviation or percentages, and statistical contrasts.
SUD + MDD, substance use disorder with comorbid depression; SUD, substance use
disorder; DAST-20, drug screening test; HDRS, Hamilton Depression Rating Scale.
aPercentages will not equal 100 as each participant may take more than one substance.
*p < 0.05; **p < 0.01; *** p ≤ 0.001.
(p = 0.038), daily number of medications (p < 0.001),
quantity and type of substances used (p < 0.001), history
of suicide attempts (p = 0.004) and number of lifetime
suicidal attempts (p = 0.002). In this sense, SUD+MDD
patients had a higher rate of medical disease comorbidity
(such as hypercholesterolemia, respiratory system diseases, or
hepatitis) and used a higher daily amount of medications
(antidepressants, anxiolytics and mood stabilizers) per day
compared to SUD only. Some of the patients with SUD only
were using antidepressants, but in all cases these medications
were prescribed for sedative or anxiety reasons, as well as,
for managing addiction. Moreover, patients with SUD +
MDD showed a higher quantity of substances used and they
were more likely to use hallucinogens, opioids, and sedatives
than patients with SUD only. Finally, we also observed
that a history of suicide attempts and number of lifetime
attempts was more probable in patients with SUD+MDD
than in those with SUD only. No other differences were
found.
Regarding clinical measures, we observed that both groups
presented substantial severity of addiction according to the
cut off points of DAST-20. Patients with SUD + MDD had
mild depressive symptomatology and only 8.6% (n = 5) were
asymptomatic at the time of participating in our study according
to HDRS scoring.
The logistics regression analysis with sociodemographic and
clinical variables as predictors for being in the dual disorder
group (SUD + MDD) showed that only the model with the
daily number of medications (β = 0.93; OR 2.55; 95% CI 1.73–
3.75; p < 0.001) and the quantity of substances used (β = 69;
OR 2.01; 95% CI 1.30–3.78; p = 0.002) correctly predicted the
patient’s group for the 76.5% of the subjects (Nagelkerke’s R2 =
0.44).
Results in Personality
According to Cronbach’ alpha coefficients for the five
ZKPQ scales, internal reliability was appropriated for
the total sample with the following results: N-Anx
0.846, Act 0.746, Sy 0.773, ImpSS 0.850, and Agg-Host
0.729.
MANCOVA analyses for the five ZKPQ scales revealed
differences among the groups for N-Anx and Sy. The subsequent
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TABLE 2 | Descriptive statistics (mean and standard error) for the Alternative Five Factor Model of personality and MANCOVA results with F and eta square (η2p) tests
according to the diagnosis and considering different covariates.
Age as a covariate Age, quantity of substances
used, and daily number of
medications as covariates
Personality traits SUD + MDD SUD only F η2p F η
2
p
Neuroticism-anxiety 11.09 ± 0.50 7.48 ± 0.45 20.66*** 0.155 12.89*** 0.104
Activity 7.84 ± 0.30 8.91 ± 0.32 2.50 0.022 0.02 0.001
General activity 4.41 ± 0.30 4.67 ± 0.18 0.32 0.005 0.36 0.003
Work activity 3.61 ± 0.23 4.56 ± 0.18 10.24** 0.083 3.04 0.027
Sociability 5.72 ± 0.49 7.07 ± 0.45 4.42* 0.038 1.14 0.010
Parties and friends 2.43 ± 0.26 3.29 ± 0.26 5.65* 0.048 3.98* 0.035
Intolerance to isolate 3.29 ± 0.30 3.78 ± 0.30 1.38 0.012 0.01 0.001
Impulsive sensation-seeking 9.51 ± 0.55 8.63 ± 0.54 1.26 0.011 1.61 0.014
Impulsivity 4.19 ± 0.31 3.16 ± 0.35 6.10* 0.051 4.37* 0.038
Sensation seeking 5.26 ± 0.41 5.47 ± 0.35 0.15 0.001 0.01 0.001
Aggression-hostility 7.96 ± 0.37 8.38 ± 0.40 0.58 0.005 0.69 0.006
SUD + MDD, substance use disorder with comorbid Major Depression Disorder; SUD, substance use disorder. *p < 0.05; **p < 0.01; ***p ≤ 0.001.
MANCOVA analyses for the subscales indicated differences for
WorkAct, Part, and Imp (see Table 2).
For the SUD +MDD group, we observed higher N-Anx (p ≤
0.001) and lower Sy (p = 0.038) than for SUD only. Moreover,
also for the SUD + MDD group, we found lower WorkAct
(p= 0.002)and Part (p = 0.019), and higher Imp (p = 0.015)
compared to SUD only.
On the other hand, the second MANCOVA analysis
considering age, the daily number of medications, and the
quantity of substances used as covariates eliminated the
differences in WorkAct and Sy appreciated previously (see
Table 2). However, the differences observed for the personality
traits of N-Anx, Part, and Imp are still maintained in the second
analysis, but with lower statistical power. In this sense, patients
with SUD+MDD presented a higher N-Anx (p ≤ 0.001), lower
Part (p = 0.049), and higher Imp (p = 0.039) than patients with
SUD only.
Finally, the calculation of the T scores (mean = 50; SD
= 10) according to population norms for the ZKPQ scales
and subscales indicated that N-Anx was above average for
both groups but this was more remarkable (+1 SD) for
patients with SUD+MDD (see Figure 1). In addition, only
for patients with SUD + MDD, WorkAct, and Sy were
both below average while Imp was higher than population
norms.
Clinical Correlates of Personality
Stepwise regression analyses for the ZKPQ scales showed that
only for patients with SUD + MDD personality was linked to
clinical variables, either SUD or MDD related. We observed that
for patients with SUD + MDD depressive symptoms (HDRS)
scoring was positively associated to N-Anx (β = 0.365; R2 =
0.106; t = 2.215; p = 0.034); the age of SUD onset was positively
linked to Act (β = 0.290; R2 = 0.068; t = 2.270; p = 0.027); and
severity of addiction (DAST-20 scoring) was positively related to
Agg-Hos (β = −0.309; R2 = 0.079; t = 2.388; p = 0.020). We
did not find any more significant correlates of personality among
other variables.
DISCUSSION
Our study sought to explore personality differences between
patients with SUD taking into account the presence of a
comorbid MDD using the psychobiological approaching of the
Alternative Five Factor Model of personality. We also aimed
to compare data from our sample with population norms, as
well as to identify clinical correlates of personality dimensions
considering SUD and MDD comorbidity.
In the first place, sociodemographic and clinical results
are in line to previous data regarding patients with SUD +
MDD and SUD only (8, 9). Moreover, extending previous
findings (1, 12, 23), we observed differences between the
groups which suggest that patients with SUD + MDD
present a sociodemographic and clinical profile characterized
by variables that are associated with a worse prognosis and
treatment outcomes (e.g., being single/separated, disability
pension/unemployment, medical disease comorbidity, suicide
attempts).
Regarding sociodemographic and clinical variables that could
predict whether or not the patient is in the dual disorder group
(SUD + MDD) we observed that from all considered variables
only the daily number of medications and the quantity of
substances used were involved. Thus, the higher daily amount
of medication and substances used implies a higher probability
of being a dual depressive patient. Such observations are in line
with previous studies since SUD + MDD are linked to more
physical illnesses (39), and psychiatric symptoms (40), as well as
polydrug use (8, 18). These observations should be considered
more in depth by future studies about personality in SUD +
MDD patients.
Frontiers in Psychiatry | www.frontiersin.org 5 January 2019 | Volume 9 | Article 764
Marquez-Arrico et al. Addiction, Comorbid Depression and Personality
FIGURE 1 | T scores according to population norms for the two groups in the scales and subscales of the ZKPQ questionnaire. SUD + MDD, Substance Use
Disorder and comorbid Major Depression Disorder. SUD, Substance Use Disorder.
In the second place, our findings for personality characteristics
pointed out that patients with SUD + MDD were more likely
to be emotionally upset, tense, worried, fearful, indecisive, lack
of self-confidence, and sensitive to criticism (higher N-Anx),
than patients with SUD only and population norms. These
results, which are observed even when controlling the quantity
of substances used and the daily number of medications,
are consistent to previous data (13) and suggest a possible
additional difficulty for patients with comorbid MDD to
regulate their emotions (41) and overcome their addiction
(42); since it is a personality trait formed by characteristics
that are associated to a non-adequate treatment adherence,
more relapses, and worse treatment outcomes (11, 12, 22).
Furthermore, the N-Anx personality trait was a clinical correlate
of depressive symptomatology, which is in line with previous
studies identifying Neuroticism as a predictor of recurrent
depressive episodes (7).
In addition, when only age is considered as a covariate
patients with SUD+MDD, show a lower preference for hard
and challenging work, an active busy life or high-energy levels
(lower WorkAct) compared with patients with SUD only and
population norms. Even though these observations are coherent
with previous findings and with the presence of depressive
symptoms, such as tiredness and low energy levels (11, 32),
this difference between the groups is no longer observed when
controlling the effect of drugs used and medications per day.
Therefore, preferring hard and challenging work and self-
reported energy levels may to be conditioned by the quantity of
substances used and medications per day rather than associated
to the presence/absence of a dual depressive disorder. These
observations should be considered by future studies and when
designing treatments for addiction, since to make the most of
the interventions, physical exercise may be included as it has
proven evident benefits (43, 44). Moreover, the age of SUD
onset for patients with SUD + MDD was a clinical correlate
for the personality trait of Act. In this sense, those patients
with an older age of SUD onset showed a higher preference
for being active, which it could be possible explained by
substance use limiting the span of activities done as a result of
prioritizing addiction related behaviors (15). On the other hand,
the activity scale of ZKPQ questionnaire appears to be sensitive
to circadian typology (45, 46), and the SUD treatment imposes
a morning circadian functioning (39, 47) which could influence
energy levels of patients during treatment. Future studies should
analyze the role of this individual difference in addict and
dual disorder patients with measures before, during, and after
treatment.
Furthermore, consistent with previous work (13) and even
when controlling the effect of drug use and daily number
of medications, we also appreciated that patients with SUD
+ MDD were characterized by a preference for being alone
instead of spending time with family and friends (lower Part)
compared to SUD only and population norms. The difference
observed in the first place for Sy is no longer founded once drug
use and medications are controlled, hence, these two variables
could be influencing the social needs in patients of our sample.
Such covariates should be considered by future studies about
personality in patients with a dual depressive disorder. Overall,
our observations could represent a higher difficulty for patients
with SUD +MDD since social support has positive implications
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for recovery in drug dependence patients (48) as well as for
preventing recurrent depressive episodes (7).
Finally, we observed that patients with SUD + MDD
presented a higher tendency to act impulsively without thinking
(higher Imp) than patients with SUD only and population
norms. These findings are in line with previous data, are
also observed once the effects of the quantity of drug use
and medications are controlled, and suggest that, even though
impulsivity is a personality trait associated with substance abuse,
when comparing patients with SUD regarding their MDD
comorbidity, those with SUD + MDD tend to show a stronger
presence of impulsivity. Hence, having both disorders could be
indicating a greater vulnerability for relapses or poor treatment
outcomes (1, 49).
Overall, to our knowledge this is the first study that explores
personality traits according to the Alternative Five Factor Model
in patients with SUD taking into account the presence of a
comorbid MDD. Even though further studies are needed, our
research could be considered a relevant approach to inform
professionals to prioritize aims during therapeutic interventions
for patients with SUD + MDD, since they exhibit different
personality characteristics than patients with SUD only. For
example, interventions for patients with SUD + MDD could
emphasize emotion and impulsivity management, as well as
strategies for extending their social network.
On the other hand, this study has limitations that should be
considered. As we used a cross-sectional design we could not
determine the manner in which diagnosis (SUD and SUD +
MDD), sociodemographic, and clinical variables interact with
personality dimensions. In this sense, longitudinal and larger
studies with other statistical methods are needed to allow more
robust approaches to assess such interactions. Moreover, we only
included male patients in our sample, with a large age range and
differing in the daily number of medications used depending on
their group. In this sense, it is widely known that dual disorder
patients had more clinical complications and tend to use more
medications than patients with SUD only related to second
diagnosis, but future research is needed to clarify the role of these
factors among personality traits that could be conditioned by
pharmacological treatment (e.g., activity and sociability). All of
these limitations together with the moderated effect sizes of our
results may limit the generalizability of our findings.
CONCLUSIONS
This work could be considered a first approach for understanding
personality characteristics in a sample of patients with
SUD taking into account MDD comorbidity, from the
psychobiological perspective of the Alternative Five Factor
Model of personality. Our findings suggest that, compared
with patients with SUD only and population norms, patients
with SUD + MDD show distinctive personality characteristics.
According to the Alternative Five Factor Model of personality,
patients with SUD+MDD are characterized by higher N-Anx
(positively associated to depressive symptoms) and Imp; as well
as by lower Part compared to patients with SUD only. In this line,
our results pointed out that the personality traits of N-Anx and
Imp which were previously associated to drug use, in our sample
are traits linked to the presence of comorbidity. The strongest
difference identified between patients with SUD + MDD and
SUD only is founded for the N-Anx trait. Hence, our findings
are suggesting that further investigation is needed to explore the
possible role of N-Anx as an endophenotype for a dual depressive
disorder. Moreover, the probability of having a dual depressive
disorder was represented by the amount of medications and
substances used; and the tendency for preferring challenging
work, as well as self-reported energy levels, is conditioned by
these two variables rather than by the presence of comorbid
depression in patients with SUD. Our findings are relevant since
previous research has linked similar characteristics to worse
prognosis and major clinical difficulties and observations may
be considered during therapeutic interventions for patients with
SUD+MDD.
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